Law
Intellectual Property Rights vs. Access to Essential Medicines
Quick fact
During the HIV/AIDS crisis, life-saving antiretroviral drugs cost around $10,000 per person per year, but by 2001, low-cost generic versions produced in India were available for under $350 a year, driving a dramatic expansion of treatment access.
Why this is interesting
Imagine a life-saving drug priced at $1,000 a month when the ingredients cost only $1—why can't someone simply make a cheaper copy? Who holds the right to decide who lives or dies?